The global market for oligosaccharides in infant nutrition is expected to witness significant growth due to increasing investments in research and innovations. Factors such as rising birth rates, the inability of mothers to breastfeed sufficiently, and the health benefits offered by oligosaccharides are driving market growth. Oligosaccharides act as prebiotics, nourishing beneficial gut bacteria, and may reduce the risk of infections and allergies in infants. As a result, infant formula manufacturers are increasingly incorporating oligosaccharides to mimic the benefits of breast milk and enhance the nutritional value of their products, driving market expansion
Access Full Report: https://databridgemarketresearch.com/reports/global-oligosaccharides-in-infant-nutrition-market
Data Bridge Market Research analyses that the Global Oligosaccharides in the Global Infant Nutrition Market is expected to grow at a CAGR of 9.0% in the forecast period of 2022 to 2029. The rising incidence of health issues in infants, such as digestive disorders and allergies, has led to a higher demand for specialized infant nutrition products, including those containing oligosaccharides.
Key Findings of the Study
Rising demand for functional food is expected to drive the market's growth rate
The rising demand for functional food in the infant nutrition market is driven by the growing awareness among parents about the importance of providing optimal nutrition to their infants. Functional food products, including those enriched with oligosaccharides, offer enhanced nutritional value and specific health benefits. Oligosaccharides, such as prebiotics, can support the development of a healthy gut microbiome, improve digestion, and enhance immune system function. As parents seek to provide the best start for their infants, the demand for functional food products containing oligosaccharides continues to increase, driving market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Segments Covered
|
Source (Bacteria, Plants, Algae, Fungi), Type (Galactoligosaccharides, Human Milk Oligosaccharides, Fructooligosaccharides), Form (Liquid, Powder)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Nissin Sugar Co. Ltd. (Japan), Yakult Pharmaceutical Industry Co., Ltd. (Japan), Kerry Group plc (Ireland), Taiwan Fructoso (Taiwan), Dupont nutrition & health (U.S.), Royal FrieslandCampina N.V. (Netherlands), Abbott (U.S.), Ingredion (U.S.), Biosynth Carbosynth. (Switzerland), Dextra Laboratories Ltd. (Thailand), Inbiose NV (Belgium), Jennewein Biotechnologie GmbH (Germany), Tereos (France), and Zuchem (U.S.) among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
|
Segment Analysis:
The oligosaccharides in infant nutrition market is segmented on the basis of source, type, and form.
- On the basis of source, the oligosaccharides in infant nutrition market is segmented into bacteria, plants, algae, fungi and others.
- On the basis of type, the oligosaccharides in infant nutrition market is segmented into galactoligosaccharides, human milk oligosaccharides and fructooligosaccharides.
- On the basis of form, the oligosaccharides in infant nutrition market is segmented into powder and liquid.
Major Players
Data Bridge Market Research recognizes the following companies as the major oligosaccharides in infant nutrition market players in oligosaccharides in infant nutrition market are Nissin Sugar Co. Ltd. (Japan), Yakult Pharmaceutical Industry Co., Ltd. (Japan), Kerry Group plc (Ireland), Taiwan Fructoso (Taiwan), Dupont nutrition & health (U.S.), Royal FrieslandCampina N.V. (Netherlands), Abbott (U.S.), Ingredion (U.S.)
Market Development
- In 2021, In order to strengthen children's immune systems, Nestle introduced the new NAN SUPREME PRO 3 formula products with five human milk oligosaccharides (2'-FL, DFL, LNT, 3'-SL, and 6'-SL).
- In 2020, Chr. Hansen purchased Jennewein Biotechnologie GmbH as well as a substantial collection of patents covering the creation of human milk oligosaccharides (HMOs) and several related legal disputes.
- In 2019, Human milk oligosaccharides (HMOs) will be developed and marketed for widespread use in medical food, functional nutrition, and dietary supplements, according to a partnership agreement signed by BASF and Glycosyn.
- In 2019, Lonza Specialty Ingredients and DuPont Nutrition & Health have a deal whereby Lonza will produce and supply CARE4U 2'-FL, a human milk oligosaccharide (HMO). The creation of scalable production is at the heart of DuPont's larger microbiome investment strategy, which includes the development of HMOs.
Regional Analysis
Geographically, the countries covered in the oligosaccharides in infant nutrition market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
Asia-Pacific is the dominant region in oligosaccharides in the infant nutrition market during the forecast period 2022-2029
Asia-Pacific dominates the oligosaccharides in the infant nutrition market due to factors such as the rising disposable income of the population, increasing awareness about the benefits of oligosaccharides in infant nutrition, and growing demand for premium infant nutrition products. The region's large consumer base, particularly in countries such as China and India, drives the market growth. Furthermore, favorable government initiatives and increasing urbanization contribute to the positive growth prospects of the oligosaccharides in the infant nutrition market in Asia-Pacific.
North America is estimated to be the fastest-growing region in oligosaccharides in the infant nutrition market for the forecast period 2022-2029
North America is expected to achieve the highest compound annual growth rate (CAGR) in the oligosaccharides in the infant nutrition market. The region's growth is driven by the increasing demand for occasional calorie sweeteners in the production of bakery and confectionery products. Consumer preferences for healthier alternatives in these food segments contribute to the rising adoption of oligosaccharides. Additionally, the presence of major players in the market and their focus on research and development activities further support the market's growth in North America.
For more detailed information about the oligosaccharides in infant nutrition market report, click here – https://www.databridgemarketresearch.com/pt/reports/global-oligosaccharides-in-infant-nutrition-market
